Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Cell Motility through Blebbing01:16

Cell Motility through Blebbing

Blebs are a type of membrane protrusion formed by the internal hydrostatic pressure of the cytoplasm. Blebs are observed in several cell types, including fibroblasts, immune cells, and single-celled organisms like the amoeba. The primary function of blebs is cell locomotion and apoptosis, but they are also found during necrosis and cell division. The life cycle of a bleb comprises an initiation phase followed by the expansion and retraction phases.
Blebbing Through the Matrix
In multicellular...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wave dispersion analysis of porous functionally graded piezoelectric sandwich panels on Kerr substrates.

Scientific reports·2026
Same author

Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy.

Frontiers in immunology·2026
Same author

A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis.

Cell metabolism·2026
Same author

Excessive vigorous exercise impairs cognitive function through a muscle-derived mitochondrial pretender.

Cell metabolism·2026
Same author

Thrombosis biomarkers: utility in early diagnosis and prognosis of severe pneumonia.

Thrombosis journal·2026
Same author

Effect of branch roadways on dynamic disaster-causing and energy dissipation characteristics of outburst gas-solid two-phase flow.

Scientific reports·2026

Related Experiment Video

Updated: Jun 23, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Nkx2.5/Csx represses myofibroblast differentiation.

Biao Hu1, Yue Ming Wu, Zhe Wu

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA.

American Journal of Respiratory Cell and Molecular Biology
|April 28, 2009
PubMed
Summary

The homeobox transcription factor Nkx2.5 (Nkx2.5) represses myofibroblast differentiation by inhibiting alpha-smooth muscle actin (alpha-SMA) gene expression. This discovery reveals a novel role for Nkx2.5 in suppressing fibrotic processes.

More Related Videos

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension
04:48

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

Related Experiment Videos

Last Updated: Jun 23, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension
04:48

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Cell Biology

Background:

  • Myofibroblasts are crucial for wound healing and fibrosis, originating from fibroblasts and marked by alpha-smooth muscle actin (alpha-SMA) expression.
  • The homeobox transcription factor Nkx2.5 is essential for heart development and cardiomyocyte differentiation.

Purpose of the Study:

  • To investigate the potential role of Nkx2.5 in regulating myofibroblast differentiation.
  • To identify and characterize Nkx2.5 binding sites within the alpha-SMA gene promoter.

Main Methods:

  • Analysis of the alpha-SMA gene promoter for Nkx2.5 binding sites.
  • Site-directed mutagenesis to assess the functional importance of identified binding sites.
  • Gel shift assays to confirm Nkx2.5 binding.
  • In vitro fibroblast culture and in vivo pulmonary fibrosis models.

Main Results:

  • Three potential Nkx2.5 binding sites (NKE1, NKE2, NKE3) were identified in the alpha-SMA promoter.
  • Mutagenesis of NKE1 and NKE3 significantly enhanced alpha-SMA promoter activity, while NKE2 had no significant effect.
  • Nkx2.5 directly bound to NKE1 and NKE3, and its ectopic expression inhibited alpha-SMA expression.
  • Nkx2.5 expression was induced by FGF in lung fibroblasts and diminished in pulmonary fibrosis.

Conclusions:

  • Nkx2.5 acts as a novel repressor of alpha-SMA gene transcription, thereby inhibiting myofibroblast differentiation.
  • Nkx2.5 may play a homeostatic role in preventing myofibroblast differentiation during normal conditions.
  • These findings suggest a new therapeutic target for fibrotic diseases.